Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Platelet-released growth factors can reduce inflammation in joint disease.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Platelet lysate is better than fetal bovine serum for growing stem cells and healing wounds.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

CS12192 effectively treats alopecia areata with better safety than current options.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

Hyaluronidase speeds up wound healing and reduces inflammation.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Entospletinib effectively prevents eye and skin GVHD in mice.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.